Spots Global Cancer Trial Database for intensity modulated radiotherapy (imrt)
Every month we try and update this database with for intensity modulated radiotherapy (imrt) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Sarcoma Preoperative Radiation With Simultaneous INTegrated Boost (SPRINT) | NCT05761054 | Soft Tissue Sar... | RT | 18 Years - | Azienda Ospedaliero-Universitaria Careggi | |
| d-Limonene +Radiation +Platinum Based Chemo for Xerostomia Prevention in Locally Advanced Head and Neck Squamous Cell Carcinoma | NCT04392622 | Xerostomia | D-Limonene Gelc... Intensity modul... Cisplatin Xerostomia ques... | 18 Years - | Stanford University | |
| d-Limonene +Radiation +Platinum Based Chemo for Xerostomia Prevention in Locally Advanced Head and Neck Squamous Cell Carcinoma | NCT04392622 | Xerostomia | D-Limonene Gelc... Intensity modul... Cisplatin Xerostomia ques... | 18 Years - | Stanford University | |
| De-intensification of Radiation & Chemotherapy in Low-Risk Human Papillomavirus-related Oropharyngeal Squamous Cell Ca | NCT01530997 | Carcinoma, Squa... Head and Neck N... Oropharyngeal N... | Intensity Modul... Cisplatin Limited surgica... | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
| Ficlatuzumab, Cisplatin and IMRT in Locally Advanced Head and Neck Squamous Cell Carcinoma | NCT02277184 | Carcinoma, Squa... | Ficlatuzumab Cisplatin Intensity Modul... | 18 Years - | University of Pittsburgh | |
| Concurrent Chemoradiotherapy Using Intensity Modulated Radiotherapy (IMRT) & Docetaxel-cisplatin (or Carboplatin) Followed by Adjuvant Chemotherapy for Inoperable Stage III Non-small-cell Lung Cancer | NCT01266512 | Lung Neoplasms | DOCETAXEL Intensity Modul... CISPLATIN | 18 Years - | Sanofi | |
| SOX-based CRT for Esophageal Cancer. | NCT03991104 | Esophageal Canc... | Oxaliplatin S-1 capsule Intensity modul... | 18 Years - 70 Years | Zhejiang Provincial People's Hospital | |
| Trial of Magnetic Resonance Imaging Guided Radiotherapy Dose Adaptation in Human Papilloma Virus Positive Oropharyngeal Cancer | NCT03224000 | Malignant Neopl... Oropharyngeal C... | Modified Barium... Swallowing Ques... Symptom Questio... Video-Strobe Pr... MRI Guided Inte... Standard-of-Car... Intensity Modul... | 18 Years - | M.D. Anderson Cancer Center | |
| Intensity Modulated Radiotherapy (IMRT) for the Pelvis Post-Hysterectomy | NCT00508703 | Uterine Cancer Cervical Cancer Endometrial Can... | Intensity Modul... CT Scan | - | M.D. Anderson Cancer Center | |
| P53 Mutational Status and cf HPV DNA for the Management of HPV-associated OPSCC | NCT03077243 | Carcinoma, Squa... Head and Neck N... Oropharyngeal N... | Intensity Modul... Cisplatin (or a... Assessment for ... | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
| Neo-RT: A Study Investigating Whether Changing the Sequence of Treatments (Starting Radiotherapy Followed by Hormone Therapy Before Surgery) is Feasible | NCT03818100 | Breast Cancer | Intensity modul... Endocrine thera... Breast conservi... | 18 Years - | Cambridge University Hospitals NHS Foundation Trust | |
| Intensity Modulated Radiotherapy (IMRT) for the Pelvis Post-Hysterectomy | NCT00508703 | Uterine Cancer Cervical Cancer Endometrial Can... | Intensity Modul... CT Scan | - | M.D. Anderson Cancer Center | |
| SOX-based CRT for Esophageal Cancer. | NCT03991104 | Esophageal Canc... | Oxaliplatin S-1 capsule Intensity modul... | 18 Years - 70 Years | Zhejiang Provincial People's Hospital | |
| PET-MRI Assessment of Early Tumor Response to Predict Outcomes of HPV-Positive Oropharynx Cancer Patients | NCT03342378 | Squamous Cell C... Oropharynx Canc... | Intensity modul... PET-MRI | 18 Years - | University of Wisconsin, Madison | |
| A Study of IMRT in Primary Bone and Soft Tissue Sarcoma | NCT02520128 | Soft Tissue Sar... Ewing Sarcoma Bone Sarcoma Chordoma | Intensity modul... | 16 Years - | University College, London | |
| P53 Mutational Status and cf HPV DNA for the Management of HPV-associated OPSCC | NCT03077243 | Carcinoma, Squa... Head and Neck N... Oropharyngeal N... | Intensity Modul... Cisplatin (or a... Assessment for ... | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
| De-intensification of Radiation & Chemotherapy in Low-Risk Human Papillomavirus-related Oropharyngeal Squamous Cell Ca | NCT01530997 | Carcinoma, Squa... Head and Neck N... Oropharyngeal N... | Intensity Modul... Cisplatin Limited surgica... | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
| Ficlatuzumab, Cisplatin and IMRT in Locally Advanced Head and Neck Squamous Cell Carcinoma | NCT02277184 | Carcinoma, Squa... | Ficlatuzumab Cisplatin Intensity Modul... | 18 Years - | University of Pittsburgh | |
| Trial Evaluating 3-year Disease Free Survival in Patients With Locally Advanced Rectal Cancer Treated With Chemoradiation Plus Induction or Consolidation Chemotherapy and Total Mesorectal Excision or Non-operative Management | NCT02008656 | Rectal Cancer | Oxaliplatin (OX... 5-Fluorouracil ... Leucovorin Capecitabine (X... intensity modul... Quality of Life... DRE-Endoscopy | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| SOX-based CRT for Esophageal Cancer. | NCT03991104 | Esophageal Canc... | Oxaliplatin S-1 capsule Intensity modul... | 18 Years - 70 Years | Zhejiang Provincial People's Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
